Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02188667 · ClinicalTrials.gov registry record · NA
Integrating Patient Reported Outcomes (I-PRO) Study for Multidisciplinary Pain Care
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT02188667: Completed NA study, sponsored by University of Florida.
NCT02188667 is a NA study that has completed, run by University of Florida. The registered enrollment target is 21 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02188667, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the impact of clinician education, electronic health record integrated patient reported outcomes, and electronic health record integrated decision support on pain-related care quality, outcomes, and service utilization.
Primary Outcome
This is a 16 item web based questionnaire about general experiences and satisfaction with providing care to patients with chronic noncancer pain. Data will be collected at baseline (June 2014) and monthly thereafter through the end of the study period (July 2014 - September 2015). Provider satisfaction data for both the treatment and control groups will be compared.
Interventions
- OTHER Providers of Novel Care
- OTHER Providers of Usual Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2014-07 |
| Est. Completion | 2016-03 |
| Phase | NA |
What the finished NCT02188667 record still lists
NCT02188667 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Providers of Novel Care is the first listed.
NCT02188667 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02188667 about?
NCT02188667 is a clinical study titled "Integrating Patient Reported Outcomes (I-PRO) Study for Multidisciplinary Pain Care". The purpose of this study is to assess the impact of clinician education, electronic health record integrated patient reported outcomes, and electronic health record integrated decision support on pain-related care quality, outcomes, and service utilization.
What is the current status of trial NCT02188667?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2014-07. Estimated completion is 2016-03.
What interventions are being tested in trial NCT02188667?
The interventions under investigation include: Providers of Novel Care (OTHER), Providers of Usual Care (OTHER).
Who is sponsoring clinical trial NCT02188667?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02188667's enrollment target sits among peer trials
21 1762nd of 2000 higher than 233 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia